Zydus Wellness Limited ZYDUSWELL NIFTY_SMALLNSE

Consumer Defensive · Packaged Foods · India

https://www.zyduswellness.com

Zydus Wellness Limited engages in the development, production, marketing, and distribution of health and wellness products in India, the Middle East, Asia, Africa, the Oceania, and internationally. It provides sugar substitute products under the Sugar Free Gold, Sugar Free Natura, and Sugar Free Green brands; milk-based health food drink under the Complan brand; glucose-based beverage under the Glucon-D brand; and I'm lite a blended sugar coated with stevia. The company also offers a range of skincare products, such as soap-free face washes, face masks, scrubs, and leave-on-products under the Everyuth brand; prickly heat and cooling powder, and hand sanitizer under the Nycil brand; and probiotic butter spread, table spread, ghee, butter, cholesterol fat-free spread, mayonnaise, and chocolate spread under the Nutralite brand. It also exports its products. The company was formerly known as Carnation Nutra Analogue Foods Limited and changed its name to Zydus Wellness Limited in January 2009. The company was founded in 1988 and is headquartered in Ahmedabad, India. Zydus Wellness Limited is a subsidiary of Zydus Lifesciences Limited.

Market & Price

Market Cap

₹16,132.16 Cr

Current Price

₹507.05

High / Low (52W)

₹524.26 / ₹373.50

Beta

-0.07

Valuation

Stock P/E

81.91

Industry PE

23.47

Forward P/E

29.00

PEG Ratio

Book Value

₹179.39

Price to Book

2.83

P/S

4.07

EV/EBITDA

38.27

Dividend Yield

0.24%

Profitability & Returns

ROCE

3.43%

ROE

3.43%

ROA

2.65%

Profit Margin

4.98%

Op Margin

14.14%

EPS (Latest Qtr)

₹5.09

EPS (TTM)

₹6.19

Balance Sheet & Liquidity

Debt/Equity

0.55

Quick Ratio

0.75

Current Ratio

1.88

Debt

₹3,202.80 Cr

Total Assets

₹10,307.80 Cr

Current Assets

₹1,366.70 Cr

Working Capital

₹638.20 Cr

Ownership

Promoter Holding

69.85%

Chg in Prom Hold

FII / Inst Holding

20.52%

Chg in FII Hold

Financial Snapshot

Enterprise Value

₹19,225.44 Cr

Total Revenue (TTM)

₹3,961.00 Cr

EBITDA

₹502.30 Cr

Free Cash Flow

₹-36.36 Cr

Operating Cash Flow

₹226.40 Cr

Shares Outstanding

₹31.82 Cr

Gross Margin

60.44%

Payout Ratio

19.35%

Growth (CAGR)

Revenue 5Y

20.67%

Profit 5Y

-14.03%

Revenue (YoY)

62.60%

Earnings (YoY)

-5.80%

PROS

Compounding revenue at 20.7% over 5 years.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

Trading at a high P/E of 81.9.
Earnings shrank at -14.0% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

Price Chart

NSE TradingView Screener.in

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Consumer Defensive).

#	Name	CMP ₹	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	ZYDUSWELL Zydus Wellness Limited NIFTY_SMALLNSE	507.05	81.91	₹16,132.16 Cr	0.24%	3.43%	3.43%	20.67%	-14.03%
2	HINDUNILVR Hindustan Unilever Limited NIFTY50NSE	2,153.50	47.62	₹5.06 L Cr	2.04%	22.15%	21.60%	2.31%	14.12%
3	ITC ITC Limited NIFTY50NSE	286.90	17.39	₹3.59 L Cr	5.58%	36.47%	29.34%	3.65%	2.54%
4	NESTLEIND Nestlé India Limited NIFTY50NSE	1,421.50	78.10	₹2.74 L Cr	0.84%	59.30%	76.34%	17.01%	23.05%
5	DMART Avenue Supermarts Limited NSE	4,054.50	88.49	₹2.64 L Cr	-	16.41%	12.94%	17.21%	7.69%
6	VBL Varun Beverages Limited NSE	528.00	56.17	₹1.79 L Cr	0.38%	19.44%	-	17.26%	26.57%
7	TATACONSUM Tata Consumer Products Limited NIFTY50NSE	1,178.40	75.78	₹1.17 L Cr	0.85%	8.29%	6.94%	13.87%	8.61%
8	MARICO Marico Limited NIFTY_MIDNSE	821.70	60.60	₹1.06 L Cr	0.49%	39.00%	41.39%	12.00%	10.61%
9	GODREJCP Godrej Consumer Products Limited NSE	1,029.30	56.49	₹1.05 L Cr	1.94%	21.44%	15.10%	4.59%	3.02%

Quarterly Results

Figures in INR.

Metric	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Dec 2025	Mar 2026
Revenue	-	450.80 Cr	910.60 Cr	857.70 Cr	963.30 Cr	1,476.10 Cr
Cost of Revenue	-	235.60 Cr	411.70 Cr	387.80 Cr	353.10 Cr	519.70 Cr
Gross Profit	-	215.20 Cr	498.90 Cr	469.90 Cr	610.20 Cr	956.40 Cr
Operating Expenses	-	205.90 Cr	321.60 Cr	325.40 Cr	605.40 Cr	746.40 Cr
Operating Income	-	9.30 Cr	177.30 Cr	144.50 Cr	4.80 Cr	210.00 Cr
EBITDA	-	18.60 Cr	190.80 Cr	158.60 Cr	55.20 Cr	271.30 Cr
Interest Expense	-	3.30 Cr	4.20 Cr	2.50 Cr	41.20 Cr	38.70 Cr
Pretax Income	-	10.10 Cr	173.40 Cr	145.30 Cr	-41.50 Cr	177.30 Cr
Tax Provision	-	3.70 Cr	1.50 Cr	17.40 Cr	-1.60 Cr	15.30 Cr
Net Income	-	6.40 Cr	171.90 Cr	127.90 Cr	-39.90 Cr	162.00 Cr
Diluted EPS	-	0.20	5.40	4.02	-1.25	5.09

Profit & Loss (Annual)

Figures in INR.

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Revenue	-	2,242.60 Cr	2,315.20 Cr	2,691.20 Cr	3,940.00 Cr
Cost of Revenue	-	1,153.00 Cr	1,146.10 Cr	1,278.10 Cr	1,566.90 Cr
Gross Profit	-	1,089.60 Cr	1,169.10 Cr	1,413.10 Cr	2,373.10 Cr
Operating Expenses	-	777.10 Cr	884.80 Cr	1,061.70 Cr	2,017.50 Cr
Operating Income	-	312.50 Cr	284.30 Cr	351.40 Cr	355.60 Cr
EBITDA	-	331.70 Cr	307.60 Cr	399.20 Cr	475.30 Cr
Interest Expense	-	15.80 Cr	23.70 Cr	12.00 Cr	98.10 Cr
Pretax Income	-	290.90 Cr	260.10 Cr	358.80 Cr	230.50 Cr
Tax Provision	-	-19.50 Cr	-6.80 Cr	11.90 Cr	33.30 Cr
Net Income	-	310.40 Cr	266.90 Cr	346.90 Cr	197.20 Cr
Diluted EPS	9.71	9.76	8.39	10.90	-

Compounded Sales Growth

5 Years:	20.67%
1 Year:	62.60%

Compounded Profit Growth

5 Years:	-14.03%
1 Year:	-5.80%

Stock Price Performance

1 Year:	+30.38%
6 Months:	+14.80%
3 Months:	+27.08%
1 Month:	-0.29%

Balance Sheet (Annual)

Figures in INR.

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Total Assets	-	5,833.10 Cr	6,148.40 Cr	6,441.90 Cr	10,307.80 Cr
Current Assets	-	907.80 Cr	1,214.30 Cr	1,104.20 Cr	1,366.70 Cr
Cash & Equivalents	-	37.00 Cr	80.00 Cr	66.70 Cr	110.60 Cr
Inventory	-	457.50 Cr	467.60 Cr	517.50 Cr	763.80 Cr
Receivables	-	207.80 Cr	283.30 Cr	367.00 Cr	383.80 Cr
Total Liabilities	-	710.50 Cr	790.90 Cr	770.30 Cr	4,481.80 Cr
Current Liabilities	-	692.40 Cr	769.40 Cr	745.50 Cr	728.50 Cr
Long Term Debt	62.50 Cr	0	-	-	3,034.90 Cr
Total Debt	-	297.30 Cr	328.70 Cr	188.30 Cr	3,202.80 Cr
Total Equity	-	5,122.60 Cr	5,357.50 Cr	5,671.60 Cr	5,826.00 Cr
Shares Outstanding	-	31.82 Cr	31.82 Cr	31.82 Cr	31.82 Cr

Cash Flows (Annual)

Figures in INR.

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow	-	91.70 Cr	246.40 Cr	380.00 Cr	226.40 Cr
Investing Cash Flow	-	-84.90 Cr	-177.70 Cr	-223.60 Cr	-2,909.90 Cr
Financing Cash Flow	-	-138.50 Cr	-25.70 Cr	-186.30 Cr	2,698.40 Cr
Capital Expenditure	-	-45.00 Cr	-28.50 Cr	-66.30 Cr	-101.70 Cr
Free Cash Flow	-	46.70 Cr	217.90 Cr	313.70 Cr	124.70 Cr
Net Change in Cash	-	-131.70 Cr	43.00 Cr	-29.90 Cr	14.90 Cr

Ratios (Annual)

Figures in %.

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Gross Margin %	-	48.6%	50.5%	52.5%	60.2%
Operating Margin %	-	13.9%	12.3%	13.1%	9.0%
Net Margin %	-	13.8%	11.5%	12.9%	5.0%
ROE %	-	6.1%	5.0%	6.1%	3.4%
ROCE %	-	6.1%	5.3%	6.2%	3.7%

Shareholding Pattern

Insiders

69.85%

Institutions

20.52%

Public Float

68.07%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for ZYDUSWELL

No recent headlines available.

ZYDUSWELL · Consumer Defensive